EcoR1 Capital, LLC - GRITSTONE ONCOLOGY INC ownership

GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 117 filers reported holding GRITSTONE ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.

Quarter-by-quarter ownership
EcoR1 Capital, LLC ownership history of GRITSTONE ONCOLOGY INC
ValueSharesWeighting
Q4 2021$81,265,000
+35.3%
6,319,232
+13.6%
2.59%
+24.0%
Q3 2021$60,056,000
+92.3%
5,560,748
+62.5%
2.09%
+79.0%
Q2 2021$31,236,000
-3.2%
3,421,2870.0%1.17%
-18.4%
Q1 2021$32,263,000
+139.3%
3,421,2870.0%1.43%
+97.4%
Q4 2020$13,480,0003,421,2870.72%
Other shareholders
GRITSTONE ONCOLOGY INC shareholders Q4 2021
NameSharesValueWeighting ↓
Versant Venture Management, LLC 3,561,150$6,125,1783.26%
Redmile Group, LLC 8,509,126$14,635,6970.70%
Avidity Partners Management LP 2,733,800$4,702,1360.19%
Frazier Life Sciences Management, L.P. 1,430,878$2,461,1100.16%
Artia Global Partners LP 95,170$163,6920.07%
Worth Venture Partners, LLC 43,772$75,2880.04%
SkyOak Wealth, LLC 60,875$104,7050.03%
Point72 Asset Management, L.P. 5,924,867$10,190,7710.03%
CORNERCAP INVESTMENT COUNSEL INC 76,811$132,1150.02%
Houlihan Financial Resource Group, Ltd. 20,000$380.02%
View complete list of GRITSTONE ONCOLOGY INC shareholders